<- Go Home
Bio-Techne Corporation
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally.
Market Cap
$12.3B
Volume
1.1M
Cash and Equivalents
$139.9M
EBITDA
$326.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$773.4M
Profit Margin
67.01%
52 Week High
$89.91
52 Week Low
$51.79
Dividend
0.41%
Price / Book Value
6.09
Price / Earnings
62.26
Price / Tangible Book Value
23.74
Enterprise Value
$12.6B
Enterprise Value / EBITDA
36.86
Operating Income
$260.0M
Return on Equity
10.40%
Return on Assets
6.11
Cash and Short Term Investments
$145.3M
Debt
$494.7M
Equity
$2.0B
Revenue
$1.2B
Unlevered FCF
$203.2M
Sector
Life Sciences Tools and Services
Category
N/A